Bayer's chloroquine donation to U.S. raises concern about FDA standards in pandemic
Posted by
www.biotecnika.org
On Mar 21, two days after President Trump first touted chloroquine
drugs as a "gamechanger" in the fight against COVID-19, administration
officials privately described what they felt was a "win" in the
President's efforts to build an emergency stockpile of the drugs.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayers-chloroquine-donation-to-u-s-raises-concern-about-fda-standards-in-pandemic/articleshow/75192031.cms
Subscribe to:
Post Comments (Atom)
Post a Comment